E FRANKLIN: Open Payments
NPI 1467416149 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 23 payments from 13 companies in 2025. Trend: 2023 $471 · 2024 $378 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $89 |
| Novo Nordisk Inc | 3 | $82 |
| ABBVIE INC. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| ABIOMED | 1 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Seqirus USA Inc | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, Ozempic, WATCHMAN FLX, TRINTELLIX, Flucelvax, Rybelsus, AIRSUPRA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
